CNBC 快讯 5月21日 10:45 礼来Retatrutide肥胖试验阳性：GLP-1赛道二阶导冲击 Eli Lilly says next-generation weight loss drug clears crucial obesity trial The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently fr… FG 100 读报告 →